Loredana Amoroso

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

Loredana Amoroso, Giovanni Erminio, Guy Makin et al. · Cancer Research and Treatment · 2017 · 63 citations · Full text

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

Angela Di Giannatale, Nathalie Dias-Gastellier, Annick S. Devos et al. · European Journal of Cancer · 2013 · 59 citations

Refractory Neuroblastoma, Medicine, Metronomic Therapy +8

Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

Chiara Brignole, Veronica Bensa, Nuno A. Fonseca et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 49 citations · Full text

Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients

Fabio Morandi, Giuliana Cangemi, Sebastiano Barco et al. · BioMed Research International · 2013 · 38 citations · Full text

Neuroblastoma Patients, Prognostic Biomarkers, Biomarker (Medicine) +15

Genomic coamplification of <i>CDK4</i>/<i>MDM2</i>/<i>FRS2</i> is associated with very poor prognosis and atypical clinical features in neuroblastoma patients

Loredana Amoroso, Marzia Ognibene, Martina Morini et al. · Genes Chromosomes and Cancer · 2019 · 34 citations

Genetics, Pathology, Cancer Biology +20